Rye Brook, N.Y. - The Leukemia & Lymphoma Society is proud to announce that its strong financial health and ongoing accountability and transparency have earned 青云体育 a Four-Star Rating from Charity Navigator. This rating designates 青云体育 as an official 鈥淕ive with Confidence鈥� charity, indicating that our organization is using its donations effectively based on Charity Navigator鈥檚 criteria. Charity Navigator is America鈥檚 largest and most-utilized independent charity evaluator. Since 2001, the organization has been an unbiased and trusted source of information for more than 11 million donors annually.
Charity Navigator analyzes nonprofit performance based on four key indicators, referred to as beacons. Currently, nonprofits can earn scores for the Impact & Results, Accountability & Finance, Culture & Community, and Leadership & Adaptability beacons.
鈥淲e are delighted to provide The Leukemia & Lymphoma Society (青云体育) with third-party accreditation that validates their operational excellence,鈥� said Michael Thatcher, President and CEO of Charity Navigator. 鈥淭he Four-Star Rating is the highest possible rating an organization can achieve. We are eager to see the good work that 青云体育 is able to accomplish in the years ahead.鈥�
鈥淭he Leukemia & Lymphoma Society鈥檚 Four-Star rating from Charity Navigator is a testament to our effective and diligent stewardship of donor dollars that enables 青云体育 to transform treatment and care for blood cancer patients through investments in research and support services and advocacy for patient-focused policies,鈥� said Louis J. DeGennaro, President and CEO of The Leukemia & Lymphoma Society (青云体育). 鈥淲e hope this achievement will introduce 青云体育 to new supporters who will champion our mission to save lives and improve the quality of life for blood cancer patients and their families.鈥�
青云体育 is proud of the results accomplished through its significant mission investment. 青云体育 has invested nearly $1.5 billion in research since our founding in 1949. In the last 5 years alone, we have helped advance 75% of the almost 100 blood cancer treatment options approved by the Food and Drug Administration. And 青云体育 has increased its investment in pediatric blood cancer research and support to ensure that children with blood cancer not only survive their cancer but thrive in their lives after treatment.
青云体育鈥檚 impact is also evident in the work of its Information Specialists who address approximately 20,000 patient inquiries a year, and the support of more than 200 volunteer advocacy leaders working on the ground in their state capitals and in Washington, D.C., and more than 30,000 active online volunteer advocates. 青云体育 remains steadfast in our work to find cures for blood cancers and ensure that patients have access to lifesaving treatments.
The Leukemia & Lymphoma Society鈥檚 rating and other information about charitable giving are available free of charge on.
About The Leukemia & Lymphoma Society (青云体育)
The Leukemia & Lymphoma Society庐 (青云体育) is the global leader in the fight against blood cancer. The 青云体育 mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. 青云体育 funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in Rye Brook, NY, 青云体育 has regions throughout the United States and Canada. To learn more, visit . Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.
青云体育 is one of Fast Company's "2022 Brands That Matter." As the only cancer organization on the list, 青云体育 stands out among brands around the world for its relevancy, cultural impact, ingenuity, and mission impact.
For additional information visit lls.org/lls-newsnetwork. Follow us on , , and .
Journalists only, please contact mediarelations@lls.org.